Affiliation:
1. 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
2. 2Department of Gastroenterology, Palo Alto Medical Foundation, San Jose, California.
3. 3Palo Alto Medical Foundation Research Institute, Palo Alto Medical Foundation, Palo Alto, California.
4. 4Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
5. 5Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
Abstract
Abstract
Background:
Gastric adenocarcinoma (GAC) is often diagnosed at advanced stages and portends a poor prognosis. We hypothesized that electronic health records (EHR) could be leveraged to identify individuals at highest risk for GAC from the population seeking routine care.
Methods:
This was a retrospective cohort study, with endpoint of GAC incidence as ascertained through linkage to an institutional tumor registry. We utilized 2010 to 2020 data from the Palo Alto Medical Foundation, a large multispecialty practice serving Northern California. The analytic cohort comprised individuals ages 40–75 receiving regular ambulatory care. Variables collected included demographic, medical, pharmaceutical, social, and familial data. Electronic phenotyping was based on rule-based methods.
Results:
The cohort comprised 316,044 individuals and approximately 2 million person-years (p-y) of observation. 157 incident GACs occurred (incidence 7.9 per 100,000 p-y), of which 102 were non-cardia GACs (incidence 5.1 per 100,000 p-y). In multivariable analysis, male sex [HR: 2.2, 95% confidence interval (CI): 1.6–3.1], older age, Asian race (HR: 2.5, 95% CI: 1.7–3.7), Hispanic ethnicity (HR: 1.9, 95% CI: 1.1–3.3), atrophic gastritis (HR: 4.6, 95% CI: 2.2–9.3), and anemia (HR: 1.9, 95% CI: 1.3–2.6) were associated with GAC risk; use of NSAID was inversely associated (HR: 0.3, 95% CI: 0.2–0.5). Older age, Asian race, Hispanic ethnicity, atrophic gastritis, and anemia were associated with non-cardia GAC.
Conclusions:
Routine EHR data can stratify the general population for GAC risk.
Impact:
Such methods may help triage populations for targeted screening efforts, such as upper endoscopy.
Funder
National Cancer Institute
NHLBI Division of Intramural Research
Center for Asian Health Research and Education, Stanford University
Publisher
American Association for Cancer Research (AACR)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献